Prosecution Insights
Prosecution Insights
Tech Center 4100 • Art Units: 1631 1632 1672 1699 1775 1796 1797 1798 1799 4100
This examiner grants 69% of resolved cases
Michael L. Hobbs operates within Tech Center 4100 and Art Unit 1631. He has managed 1174 resolved cases. His allowance rate is 68.8 percent. This 68.8 percent rate indicates the frequency of patent grants among the 1174 cases he has processed. Practitioners can use this figure to set expectations for the likelihood of issuance.
The data shows an interview lift of 28.2 percent. This 28.2 percent increase in allowance probability following an interview suggests that verbal communication is a productive tool for resolving issues. Applicants may find that the 28.2 percent lift justifies the time and resources required for an interview. This strategy is applicable to cases within Art Unit 1631.
The median time to allowance is 1225 days. This 1225 days duration provides a timeline for the prosecution process. With 1174 resolved cases, the 68.8 percent allowance rate is a stable indicator of his general approach. The 1225 days pendency is a key factor for applicants to consider when managing their patent portfolios.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18415950 | ASSAY CARTRIDGE AND MANUFACTURING METHOD OF ASSAY STRIP | Non-Final OA | FUJIFILM Corporation |
| 18432104 | CULTURE SYSTEMS | Non-Final OA | HONDA MOTOR CO., LTD. |
| 18596854 | GEL-ENCAPSULATED CELL PRODUCTION APPARATUS AND CELL CULTURE SYSTEM | Non-Final OA | CANON KABUSHIKI KAISHA |
| 18035222 | MICROFLUIDIC DEVICES AND METHODS FOR THE DEVELOPMENT OF NEURAL TUBE-LIKE TISSUES OR NEURAL SPHEROIDS | Non-Final OA | The Regents of the University of Michigan |
| 18573720 | SYSTEMS AND METHODS FOR MONITORING PACKED-BED CELL CULTURE | Non-Final OA | CORNING INCORPORATED |
| 18680826 | ELECTROCHEMICAL LEACHING FOR NUTRIENT DELIVERY IN WATER | Non-Final OA | Battelle Memorial Institute |
| 18621550 | MICROFLUIDIC INDUCTION OF RESEARCH BASED NEURAL INJURY | Non-Final OA | Worcester Polytechnic Institute |
| 18443755 | EJECTOR EQUIPPED FERMENTER | Non-Final OA | Novozymes A/S |
| 17910911 | SYSTEMS, METHODS, AND DEVICES FOR EX VIVO ANALYSIS OF RESECTED TISSUE SAMPLES | Non-Final OA | The United States of America,as represented by the Secretary,Department of Health and Human Services |
| 18566827 | CELL CULTURE VESSEL FOR USE IN MANUFACTURING CELL PRODUCTS | Non-Final OA | Geoffrey L. Hodge |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy